Vertex Pharmaceuticals, Inc. VRTX: $207.15

50 Northern Avenue, Boston, MA, US. | Sector: Health Technology | Exchange: NASDAQ | Web: http://www.vrtx.com

  • Market Cap$55.11B
  • Next Earning Date2020-10-29
  • Change (52 Weeks)8.80%
  • Low (52 Weeks)$189.35
  • Insider Activity


    Sold Shares
    The Insiders have sold -459,579 shares in the last 6 months.

    Insider Activity of Last 6 Months


    Title
    Name
    Total Bought
    Total Sold
    EVP & Chief Financial OfficerCharles F. Wagner0-700
    EVP and CFOCharles F. Wagner0-547
    DirectorAlan M. Garber2,9630
    SVP & ControllerPaul M. Silva4,632-9,415
    Executive Chairman; DirectorJeffrey M. Leiden265,603-581,506
    DirectorWilliam D. Young4,5270
    DirectorBruce I. Sachs49,878-90,000
    DirectorMargaret G. McGlynn2,963-3,707
    DirectorTerrence C. Kearney4,5270
    DirectorLloyd A. Carney1,3980
    DirectorYuchun Lee7,652-6,250
    EVP, Global Research and CSODavid Matthew Altshuler8,409-16,900
    EVP, Chief Patient OfficerAmit K. Sachdev70,383-140,824
    DirectorSangeeta N. Bhatia10,127-20,197
    DirectorDiana L. McKenzie1,7800
    EVP, Chief Commercial OfficerStuart A. Arbuckle5,892-11,897
    EVP and CMOCarmen Bozic0-311
    EVP, Chief Adm, Leg & BD OffMichael J. Parini12,659-25,386
    CEO & President; DirectorReshma Kewalramani4,147-8,393
    EVP, Chief Regulatory Officer966-2,052

    What is Insider Activity?

    Insider activity refers to company insiders, usually top order executives and directors, buying and selling shares of the company.

    The legendary investment manager, Peter Lynch once said, "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”

    When insiders (Directors, CEO, CTO and other top-level executives) of a company are buying shares, it provides more confidence for Outsiders (Traders) to speculate that the company’s stock price might increase, which leads them to take more buy positions, driving the share value higher.

    Latest News About Vertex Pharmaceuticals, Inc.